IPO Premiums
IPO calendar
ILINDOMIMListed

Indo-MIM Limited

Bookbuilding IPO · NSE, BSE

Price band
₹461 – ₹485
Lot size
30 shares
Issue amount
₹3,811.21 cr
Total subscription
72.37×
Current price₹1,162.5
Listing price ₹700
Watch live price ↗
Opens
23 Jul 2026
Closes
27 Jul 2026
Allotment
28 Jul 2026
Listing
30 Jul 2026

Offer at a glance

Issue overview

Issue size
7,86,00,300 shares
Face value
₹1 per share
Minimum investment
₹13,830
Fresh issue
₹500 cr
Offer for sale
₹3,321.11 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,550
Issue type
Bookbuilding IPO
Shares before issue
48,20,30,772
Shares after issue
49,44,62,350

Lot sizes

CategoryLotsSharesAmount
RETAIL130₹14,550
sHNI14420₹2,03,700
bHNI692,070₹10,03,950

Share reservation

ANCHOR29.93%
QIB19.94%
HNI14.96%
RETAIL34.91%
Employee0.25%

Subscription & GMP

Subscription by category

Total subscribed72.37×

Reported 27 Jul 2026

QIB204.47×
NIB50.65×
RETAIL6.67×
EMPLOYEES9.44×
HNIs(10L+)57.69×
HNIs(2-10L)36.55×

GMP history

0111.522314 Apr: ₹017 Jul: ₹8517 Jul: ₹017 Jul: ₹10218 Jul: ₹15018 Jul: ₹14518 Jul: ₹16818 Jul: ₹13519 Jul: ₹18719 Jul: ₹16319 Jul: ₹17919 Jul: ₹16920 Jul: ₹21620 Jul: ₹19320 Jul: ₹20320 Jul: ₹22321 Jul: ₹20221 Jul: ₹19321 Jul: ₹18021 Jul: ₹17321 Jul: ₹19521 Jul: ₹18022 Jul: ₹19222 Jul: ₹18122 Jul: ₹18323 Jul: ₹18723 Jul: ₹19823 Jul: ₹19023 Jul: ₹19023 Jul: ₹18023 Jul: ₹18324 Jul: ₹16724 Jul: ₹16224 Jul: ₹162.524 Jul: ₹17524 Jul: ₹18025 Jul: ₹18925 Jul: ₹18126 Jul: ₹18627 Jul: ₹20027 Jul: ₹19027 Jul: ₹19327 Jul: ₹19827 Jul: ₹19827 Jul: ₹19627 Jul: ₹20328 Jul: ₹19328 Jul: ₹19128 Jul: ₹18528 Jul: ₹19229 Jul: ₹18129 Jul: ₹18029 Jul: ₹17629 Jul: ₹17329 Jul: ₹17029 Jul: ₹16629 Jul: ₹16029 Jul: ₹16529 Jul: ₹17029 Jul: ₹17329 Jul: ₹17830 Jul: ₹184
14 Apr₹18430 Jul

Day-wise demand

23 Jul1.14×
24 Jul3.09×
27 Jul72.37×

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL9,14,67045,63,791
EMPLOYEES026,559
HNIs(10L +)18,6672,09,894
HNIs (2-10L)9,3333,20,302

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs760.211,55,437.51
FIIs051,291.66
FIs069,819.2
Mutual Funds015,340.88
Others018,985.77
RETAIL1,330.858,881.89
HNIs 2+190.126,948.48
HNIs 10+380.2421,937.76
EMPLOYEES9.791.6

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
02,0004,0006,000Mar-24 · Revenue: 2,900.38Mar-24 · Profit after tax: 283.73Mar-24Mar-25 · Revenue: 3,373.97Mar-25 · Profit after tax: 423.73Mar-25Mar-26 · Revenue: 4,320.7Mar-26 · Profit after tax: 533.54Mar-26
RevenueProfit after tax

Key performance indicators

MetricMar-26Mar-25Mar-24
EPS11.068.795.89
ROE21.2619.9414.01
ROCE26.623.5119.59
RONW000
PRE IPO(PE)43.8500
POST IPO(PE)000

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
INDO-MIM Limited43.8501.0058.2421.2611.06
Jiangsu Gian Technology Co, Limited148.0000165.133.103.91

Company information

Company profile

Indo-MIM, incorporated in 1996, is a global leader in precision engineering components manufacturing using metal injection molding (MIM) technology. The company provides end-to-end solutions including mold design, tooling, machining, finishing, and assembly, and also leverages advanced technologies such as investment casting, ceramic injection molding, precision machining, and 3D metal printing. It serves diverse industries like automotive, defence, medical, consumer, and aerospace, with over 6,400 products manufactured in FY2025. Its portfolio includes critical components such as safety and fuel system parts for automobiles, firearm components for defence, surgical device parts for medical use, and high-precision aerospace components. With a global customer base of over 1,000 clients, the company operates 15 manufacturing facilities across India, the US, UK, and Mexico, supported by international sales offices and representatives across multiple countries, making it one of the largest MIM capacity holders globally.

Strengths

  • Global Leader in MIM Manufacturing: The company is the world's largest manufacturer of precision engineering components using Metal Injection Moulding (MIM) technology, offering complete product development and manufacturing solutions.
  • Diversified Product Portfolio: It serves multiple industries, including automotive, defence, medical, aerospace, and consumer goods, reducing dependence on any single sector.
  • Integrated Global Manufacturing Network: With manufacturing facilities across India, the USA, the UK, and Mexico, the company benefits from strong global reach, scalability, and efficient customer support.

Risk factors

  • No Long-Term Customer Commitments: The company mainly receives business through purchase orders and does not have long-term contracts with most customers. Any reduction or cancellation of orders could impact revenue.
  • Raw Material Import Dependence: A significant portion of raw materials is imported, making the business sensitive to currency fluctuations, import regulations, and global market conditions.
  • Manufacturing Disruption Risk: The company's operations depend on multiple manufacturing facilities. Any disruption due to equipment breakdowns, labour issues, or unforeseen events could affect production and profitability.

Promoters

Green Meadows Investments Ltd

Krishna Chivukula

Krishna Chivukula Jr.

Raj Chivukula

Jagadamba Chandrasekhar

Registrar & documents

Lead manager

Axis Capital Limited, Hdfc Bank Limited, ICICI Securities Limited, Kotak Mahindra Capital Company, SBI Capital Markets Limited

Registered office

5(P), KIADB Industrial Area, Hoskote, Bangalore Urban, Karnataka, 562114

+91 81 2347 9565

[email protected]Company website ↗

Understanding INDOMIM IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.